Novanta (NOVT) Research & Development (2010 - 2026)

Novanta (NOVT) has reported Research & Development for 17 consecutive years, with $24.0 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Research & Development fell 5.22% year-over-year to $24.0 million; the trailing twelve-month figure through Jul 2026 stood at $94.2 million (down 2.98% YoY), and the FY2025 full-year result was $95.5 million, changed 0.03% from the prior year.
• Research & Development climbed to $24.0 million in Q3 2026 per NOVT's latest filing, from $23.3 million in the prior quarter.
• Across five years, Research & Development topped out at $25.3 million in Q2 2025 and bottomed at $20.9 million in Q2 2022.
• Historically, Research & Development has averaged $23.1 million across 5 years, with a median of $23.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Research & Development rose 27.33% in 2022, then retreated 9.56% in 2025.
• Over 5 years, Research & Development stood at $21.9 million in 2022, then climbed by 7.07% to $23.5 million in 2023, then grew by 7.82% to $25.3 million in 2024, then declined by 9.56% to $22.9 million in 2025, then rose by 4.81% to $24.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $24.0 million, $23.3 million, and $22.9 million for Q3 2026, Q2 2026, and Q4 2025 respectively.